Continuum Health Ventures
Continuum Health Ventures is an early-stage venture capital firm founded in 2021 and based in Toronto, Canada. The firm specializes in investing in the healthcare sector, with a particular focus on digital health, health technology, and longevity. Continuum Health Ventures seeks to support innovative companies that aim to enhance healthspan and advance preventative and precision health solutions. By targeting investments in the United States, Canada, and Europe, the firm is committed to fostering advancements that can significantly improve health outcomes and address the challenges associated with aging.
CardiaTec Biosciences
Seed Round in 2024
CardiaTec is a digital biotechnology company focused on revolutionizing cardiovascular drug discovery through the integration of artificial intelligence and specialized expertise. The company aims to transform the understanding of cardiovascular disease by developing AI-driven platforms for target identification and novel drug discovery. This approach seeks to provide effective therapeutics for cardiovascular diseases, addressing significant gaps in diagnostics, patient stratification, and treatment options for conditions such as coronary artery disease. By leveraging advanced technology and scientific knowledge, CardiaTec is dedicated to improving healthcare outcomes related to cardiovascular health.
Immunis
Venture Round in 2024
Immunis is a private biotechnology company focused on creating innovative therapies to address immune decline associated with aging and various diseases. The company is developing a stem cell-derived treatment that utilizes human stem cells to generate specific populations of cells. These engineered cells are designed to secrete therapeutic factors that can help restore and modulate the immune system. By harnessing the potential of stem cells, Immunis aims to provide effective solutions for improving immune health and enhancing patient outcomes.
BeeKeeperAI
Series A in 2023
Developer of a secure collaboration platform designed to create secure data access to support impactful algorithm validation and development. The company's platform supports end-to-end data and algorithm encryption that ensures data security, it uses primary data from the source rather than synthetic or de-identified data, eliminates the risk of data exfiltration and interrogation of the algorithm IP from insiders and third parties, and acts as the middleman and matchmaker between data stewards and algorithm developers, helping healthcare organizations in keeping their data secure in their private cloud infrastructure.
Immunis is a private biotechnology company focused on creating innovative therapies to address immune decline associated with aging and various diseases. The company is developing a stem cell-derived treatment that utilizes human stem cells to generate specific populations of cells. These engineered cells are designed to secrete therapeutic factors that can help restore and modulate the immune system. By harnessing the potential of stem cells, Immunis aims to provide effective solutions for improving immune health and enhancing patient outcomes.
Enara Health
Seed Round in 2022
Enara Health is a healthcare company that focuses on personalized weight loss programs through a comprehensive platform. By collaborating with professionals such as doctors and dietitians, the company leverages an algorithm that integrates key insights from genetic information, blood work, and individual medical and weight histories. This data-driven approach allows medical providers to create tailored nutrition, exercise, and medication plans aimed at preventing obesity-related diseases and promoting effective weight loss. Enara Health's mission is to enhance obesity treatment and support individuals in adopting healthier lifestyles.
Sanctuary Cognitive Systems Corporation
Series A in 2022
Sanctuary AI, founded in January 2018 and based in Vancouver, Canada, is focused on developing synthetic humans, referred to as "synths." The company's mission is to create robots that are indistinguishable from humans in physical appearance, cognitive abilities, and emotional responses. In addition to advancing cutting-edge technology, Sanctuary AI is committed to addressing the ethical implications associated with the creation of human-like machines.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at
support@teaserclub.com. Your feedback is most welcome.